Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.58 |
| ▸ | CES2 | O00748 | 5/20 | 0.58 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 4/20 | 0.43 |
| ▸ | PPARD | Q03181 | 4/20 | 0.43 |
| ▸ | PPARA | Q07869 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30197707 | 0.97 | CES1 (0.55) | CES1CES2HAO1ALDH1A1TP53 | |
| Hydrochloric Acid SCHEMBL29053917 | 0.97 | CES1 (0.55) | CES1CES2HAO1ALDH1A1TP53 | |
| SCHEMBL30197621 | 0.97 | CES1 (0.55) | CES1CES2HAO1ALDH1A1TP53 | |
| SCHEMBL5917740 | 0.94 | HAO1 (0.64) | CES1CES2HAO1ALDH1A1KMT2A | |
| SCHEMBL534886 | 0.94 | CES1 (0.52) | CES1CES2HAO1ALDH1A1TP53 | |
| SCHEMBL23361518 | 0.92 | HAO1 (0.68) | CES1CES2HAO1ALDH1A1KMT2A | |
| SCHEMBL949144 | 0.92 | CES1 (0.50) | CES1CES2HAO1ALDH1A1TP53 | |
| SCHEMBL30943146 | 0.92 | HAO1 (0.68) | CES1CES2HAO1ALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL20399921 | 0.92 | HAO1 (0.61) | CES1CES2HAO1ALDH1A1KMT2A | |
| SCHEMBL30690199 | 0.92 | HAO1 (0.68) | CES1CES2HAO1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110845987-A | High-performance copolyamide hot melt adhesive composition | 南通协鑫热熔胶有限公司 | 2020-02-28 | — | — | CN | claimed |
| US-9828324-B2 | Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom | SIRRUS, INC. (US) | 2017-11-28 | — | — | US | claimed |
| US-20160068618-A1 | METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM | SIRRUS, INC. | 2016-03-10 | — | — | US | claimed |
| US-20140275400-A1 | METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM | SIRRUS, INC. | 2014-09-18 | — | — | US | claimed |
| EP-0912467-B1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE SA (FR) | 2002-04-24 | — | — | EP | claimed |
| CN-119798279-A | RAS inhibitors | 锐新医药公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119462822-A | RAS inhibitors | 锐新医药公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119156393-A | Cyclic compound, preparation method and medical application thereof | 翰森生物有限责任公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118922423-A | RAS inhibitors | 锐新医药公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118679169-A | RAS inhibitors | 锐新医药公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118561952-A | RAS inhibitors | 锐新医药公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118234731-A | RAS inhibitors | 锐新医药公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-0083690-A1 | Polyamide acid composition for preparing polyimide and process for preparing polyimide from the same | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1983-07-20 | — | — | EP | disclosed |
| US-4208425-A | VIRICIDES | STERLING DRUG INC. (US) | 1980-06-17 | — | — | US | disclosed |
| US-4171371-A | Diketones | STERLING DRUG INC. (US) | 1979-10-16 | — | — | US | disclosed |
| US-4153719-A | Aromatic diketones | STERLING DRUG INC. (US) | 1979-05-08 | — | — | US | disclosed |
| US-4096280-A | Arylenedioxy-bis-diketones | STERLING DRUG INC. (US) | 1978-06-20 | — | — | US | disclosed |
| US-4093617-A | ENZYME INHIBITORS | ICN PHARMACEUTICALS, INC. (US) | 1978-06-06 | — | — | US | disclosed |
| US-4051229-A | REDUCTION OF ALKALI OR ALKALINE EARTH CHLORATE IN SULFURIC OR HYDROCHLORIC ACID WITH COMPLEX B-DIKETONE-PALLADIUM CATALYST | THE JAPAN CARLIT CO., LTD. (JA) | 1977-09-27 | — | — | US | disclosed |
| US-4036605-A | CATALYZING OXIDATION OF HYDROCARBONS WITH A B-KETOENOLATE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275400-A1 | METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM | BCKDK, ILK, PKM | CES1 3934/4885CES2 3761/4885HAO1 1011/4885 |
| US-20160068618-A1 | METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM | MSMO1, PKM, KHK | CES1 3525/4885CES2 3526/4885HAO1 1071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.